The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Papatheodoridis, George V  [Clear All Filters]
Journal Article
Papatheodoridis, G. V., Cholongitas E., Archimandritis A. J., & Burroughs A. K. (2009).  Current management of hepatitis B virus infection before and after liver transplantation.. Liver Int. 29(9), 1294-305.
Kostas, A., Siakavellas S. I., Kosmidis C., Takou A., Nikou J., Maropoulos G., et al. (2017).  Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.. World J Gastroenterol. 23(41), 7387-7396.
Cholongitas, E., Haidich A-B., Apostolidou-Kiouti F., Chalevas P., & Papatheodoridis G. V. (2018).  Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.. Ann Gastroenterol. 31(4), 480-490.
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Cholongitas, E., Papatheodoridis G. V., & Burroughs A. K. (2010).  Liver grafts from anti-hepatitis B core positive donors: a systematic review.. J Hepatol. 52(2), 272-9.
Papatheodoridis, G. V., Chrysanthos N., Cholongitas E., Pavlou E., Apergis G., Tiniakos D. G., et al. (2009).  Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.. J Hepatol. 51(5), 931-8.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Pipili, C. L., Papatheodoridis G. V., & Cholongitas E. C. (2013).  Treatment of hepatitis B in patients with chronic kidney disease.. Kidney Int. 84(5), 880-5.
Papatheodoridis, G. V., Manolakopoulos S., Touloumi G., Vourli G., Raptopoulou-Gigi M., Vafiadis-Zoumbouli I., et al. (2011).  Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece c. Gut. 60(8), 1109-16.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.